ASH 2018 | Current hurdles in the treatment of CLL
VJHemOnc is committed to improving our service to you
Thanks for your feedback, this will help us improve our content for you!
Speaking the American Society of Hematology (ASH) 2018 Annual Meeting and Exposition, held in San Diego, CA, Lindsey Roeker, MD, of the Memorial Sloan Kettering Cancer Center, New York City, NY, discusses her perspective on the challenges facing the treatment of chronic lymphocytic leukemia (CLL). Dr Roeker highlights the need to find the best treatment combinations in the front-line setting as a key area.
Get great new content delivered to your inboxSign up